624 Implementation of a Collaborative Drug Therapy Management Protocol in an Adult Burn Clinic

por Boyd, Allison N, Walroth, Todd A, Hartman, Brett C
Publicado 2022

532 The Impact of a Clinical Pharmacist on Medication Management in an Adult Burn Clinic

por Boyd, Allison, Walroth, Todd, Meadows, Katherine, Spera, Leigh, Hartman, Brett
Publicado 2023

742 Evaluation of Anti-Xa Levels and Venous Thromboembolism Prophylaxis with Enoxaparin in Burn Patients

por Boyd, Allison, Walroth, Todd, Hartman, Brett, Bjornstad, Matthew, Garelli, Alyssa, Spera, Leigh, Grooms, Cortni
Publicado 2023

508 A Case Report of Trichosporon asahii Burn Infection: A Not-So-Fungi

por Boyd, Allison N, Walroth, Todd A, Blunier, Abbie, Harris, William H, Hartman, Brett C
Publicado 2022

342. Secondary Infections following Tocilizumab for Treatment of COVID-19 Pneumonia

por Warner, Adam, Abbas, Mujahed, Avner, Benjamin S, Flynn, Thomas E, Walroth, Todd A, Jagger, Brett W
Publicado 2021

726 Evaluating Outcomes and Pharmacoeconomics Associated with Collagenase Use in Burn Patients

por Boyd, Allison N, Walroth, Todd A, Eberle, Madilyn, Grooms, Cortni, Hull, Victoria, Hartman, Brett C
Publicado 2022

117 Evaluating Predicted vs. Actual Vancomycin Pharmacokinetic Target Attainment Using AUC Dosing

por Boyd, Allison N, Walroth, Todd A, Bollinger, Christopher, Candidate, M B A, Hartman, Brett C
Publicado 2022

Changes in clinical markers observed from pharmacist-managed cardiovascular risk reduction clinics in federally qualified health centers: A retrospective cohort study

por Gonzalvo, Jasmine D., Meredith, Ashley H., Pastakia, Sonak D., Peters, Michael, Eberle, Madilyn, Schmelz, Andrew N., Pence, Lauren, Triboletti, Jessica S., Walroth, Todd A.
Publicado 2023